Hypertension treatment in the Asia-Pacific: the role of and treatment strategies with nebivolol-Reference-Cited by-同舟云学术

Hypertension treatment in the Asia-Pacific: the role of and treatment strategies with nebivolol

Published:2016-02 Issue:1 Volume:8 Page:22-26
ISSN:1759-1104
Container-title:Heart Asia
language:en
Short-container-title:Heart Asia

Author:

Kim Cheol-Ho,Abelardo Nelson,Buranakitjaroen Peera,Krittayaphong Rungroj,Lim Chin Hock,Park Sung-Ha,Pham Nguyen Vinh,Rogelio Gregorio,Wong Bernard,Low Lip Ping

Publisher

BMJ

Subject

Cardiology and Cardiovascular Medicine

Reference60 articles.

1. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8);James;JAMA,2014

2. Beta-blockers in the management of hypertension: focus on nebivolol;Wojciechowski;Expert Rev Cardiovasc Ther,2008

3. Global burden of blood-pressure-related disease, 2001;Lawes;Lancet,2008

4. The burden of hypertension;Kintscher;EuroIntervention,2013

5. Global burden of hypertension: analysis of worldwide data;Kearney;Lancet,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypertension and Type 2 Diabetes—The Novel Treatment Possibilities;International Journal of Molecular Sciences;2022-06-10

2. Beta-Blockers for Hypertension in Asian Population;Hypertension and Cardiovascular Disease in Asia;2022

3. Real-world efficacy and safety of nebivolol in Korean patients with hypertension from the BENEFIT KOREA study;Journal of Hypertension;2020-03

4. Nebivolol in the treatment of arterial hypertension;Basic & Clinical Pharmacology & Toxicology;2019-07-04

5. What is the Real Efficacy of Beta-Blockers for the Treatment of Essential Hypertension?;Current Pharmaceutical Design;2017-12-04